Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableActive Not RecruitingNCT05696444
What this trial is testing

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

Who this might be right for
Bladder CancerProstate CancerKidney Cancer+6 more
Medtronic - MITG 144
Not applicableWithdrawnNCT02370342
What this trial is testing

Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery

Who this might be right for
Renal CarcinomaRenal Mass
University of Southern California
Testing effectiveness (Phase 2)Active Not RecruitingNCT05501054
What this trial is testing

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00002466
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer

Who this might be right for
Kidney CancerSarcoma
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01471002
What this trial is testing

Study to Evaluate the Efficacy of Percutaneous Cryoablation for Renal Tumours < 4cm in Patients Who Are Not Candidates for Partial Nephrectomy

Who this might be right for
Renal Tumors Less Than 4 cm
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Not applicableStudy completedNCT00897637
What this trial is testing

Gene Expression Profiles to Categorize Wilms Tumors

Who this might be right for
Recurrent Wilms Tumor and Other Childhood Kidney TumorsStage I Wilms TumorStage II Wilms Tumor+3 more
Children's Oncology Group 600
Testing effectiveness (Phase 2)UnknownNCT00626509
What this trial is testing

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Gruppo Italiano Carcinoma Renale 110
Not applicableStudy completedNCT03655587
What this trial is testing

Impact of an Orthotic Intervention in Children With Peripheral Neuropathy

Who this might be right for
Gait, Drop FootChemotherapy-induced Peripheral NeuropathyAcute Lymphocytic Leukemia, Pediatric+2 more
Children's Hospitals and Clinics of Minnesota 27
Not applicableStudy completedNCT03161145
What this trial is testing

Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 297
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Not applicableWithdrawnNCT02778295
What this trial is testing

Biomarker for Patients With Fabry Disease (BioFabry)

Who this might be right for
AngiokeratomasChronic Kidney DiseaseOcular Abnormalities+1 more
CENTOGENE GmbH Rostock
Testing effectiveness (Phase 2)Ended earlyNCT01147536
What this trial is testing

Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence

Who this might be right for
Renal Cell Carcinoma
Agenus Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00053209
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 46
Large-scale testing (Phase 3)Study completedNCT00945009
What this trial is testing

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Who this might be right for
Adult Kidney Wilms TumorBeckwith-Wiedemann SyndromeChildhood Kidney Wilms Tumor+7 more
Children's Oncology Group 249
Post-approval studies (Phase 4)Ended earlyNCT03655821
What this trial is testing

Dose Individualization of Pemetrexed - IMPROVE-II

Who this might be right for
Non Small Cell Lung CancerMesothelioma
Radboud University Medical Center 81
Testing effectiveness (Phase 2)UnknownNCT04049344
What this trial is testing

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Zhejiang Cancer Hospital 25
Early research (Phase 1)WithdrawnNCT00445757
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03907657
What this trial is testing

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

Who this might be right for
Von-Hippel LindauKidney Disease, Chronic
UNC Lineberger Comprehensive Cancer Center 15
Next Page